Publications by authors named "Wan Huh"

Claim this Profile
D
Differential glycemic effects of DWP16001 in diabetic dogs according to baseline glycemic status: a multicenter randomized controlled trial.
Ju-Hyun An, Byung-Gee Ko, Hyun Namkung, Hye-Gyu Lee, Hyun-Woo Lim, Wan Huh

BMC Vet Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes.
Sae Im Jeong, Mu Seong Ban, Jun-Gi Hwang, Min-Kyu Park, Soo Lim, Wan Huh

Diabetes Obes Metab· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.
Tae Seo Sohn, Kyung-Ah Han, Yonghyun Kim, Byung-Wan Lee, Suk Chon, Wan Huh

Diabetes Obes Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the sodium-glucose cotransporter-2 inhibitor, DWP16001, as an add-on therapy to insulin for diabetic dogs: A pilot study.
Ju-Hyun An, Han-Sol Choi, Ji-Soo Choi, Hyun-Woo Lim, Wan Huh

Vet Med Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects.
Sukyong Yoon, Min Soo Park, Byung Hak Jin, Hyobin Shin, Jaejin Na, Wan Huh

Expert Opin Drug Metab Toxicol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trial.
Ye Seul Yang, Kyung Wan Min, Seok-O Park, Kyung-Soo Kim, Jae Myung Yu, Wan Huh

Diabetes Obes Metab· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults.
Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang

Br J Clin Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjects.
Byungwook Kim, Ki Young Huh, Jun Gi Hwang, JaeJin Nah, Wan Huh

Br J Clin Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects.
Jun Gi Hwang, SeungHwan Lee, Wan Huh, Jumi Han, Jaeseong Oh

Br J Clin Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of safety and anti-obesity effects of DWP16001 in naturally obese dogs.
Beomseok Rhee, Rahman Md Mahbubur, Changfan Jin, Ji-Soo Choi, Hyun-Woo Lim, Wan Huh

BMC Vet Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of poloxamer-based thermo-sensitive sol-gel agent on urethral stricture after transurethral resection of the prostate for benign prostatic hyperplasia: a multicentre, single-blinded, randomised controlled trial.
Jae Hoon Chung, Kyu Shik Kim, Jae Duck Choi, Tae Hyo Kim, Ki Soo Lee, Wan Huh

BJU Int· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis